Ironwood’s Phase III Data Could Expand Linzess Market Share

 
• By Alaric DeArment
  
Phase III pediatric data could expand market share for Ironwood's Linzess • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas